Innoviva (INVA) Work In Process (2012 - 2026)
Innoviva (INVA) reported Work In Process of $17.3 million for Q1 2026, down 36.84% on a YoY basis from $27.4 million in Q1 2025, and down 3.07% quarter-over-quarter from $17.9 million in Q4 2025.
Innoviva (INVA) Work In Process (2012 - 2026) Analysis & Trends
Innoviva has reported Work In Process for 8 years, with the latest figure at $17.3 million in Q1 2026.
- For the quarter ending Q1 2026, Work In Process fell 36.84% year-over-year to $17.3 million; the trailing twelve-month figure through Mar 2026 stood at $17.3 million (down 36.84% YoY), and the FY2025 full-year result was $17.9 million, down 12.95% from the prior year.
- Work In Process for Q1 2026 stood at $17.3 million, down from $17.9 million in the prior quarter.
- The five-year high for Work In Process was $54.1 million in Q3 2022, with the low at $13.2 million in Q3 2023.
- Historically, Work In Process has averaged $23.6 million across 5 years, with a median of $20.5 million in 2024.
- Annual changes were most pronounced in 2023 — Work In Process slumped 75.56% — and 2024, when it jumped 54.18%.
- Innoviva's Work In Process stood at $25.1 million in 2022, then sank by 37.45% to $15.7 million in 2023, then surged by 31.01% to $20.5 million in 2024, then fell by 12.95% to $17.9 million in 2025, then fell by 3.07% to $17.3 million in 2026.
- The last three Work In Process figures came in at $17.3 million (Q1 2026), $17.9 million (Q4 2025), and $18.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | Innoviva | 1.69 Bn | 1.08 Bn | 75.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.32 Mn |
| Dec 31, 2025 | 17.87 Mn |
| Sep 30, 2025 | 18.67 Mn |
| Jun 30, 2025 | 34.15 Mn |
| Mar 31, 2025 | 27.43 Mn |
| Dec 31, 2024 | 20.53 Mn |
| Sep 30, 2024 | 20.40 Mn |
| Jun 30, 2024 | 22.80 Mn |
| Mar 31, 2024 | 20.20 Mn |
| Dec 31, 2023 | 15.67 Mn |
| Sep 30, 2023 | 13.23 Mn |
| Jun 30, 2023 | 23.87 Mn |
| Mar 31, 2023 | 22.54 Mn |
| Dec 31, 2022 | 25.05 Mn |
| Sep 30, 2022 | 54.13 Mn |
| Mar 31, 2014 | 2.23 Mn |
| Dec 31, 2013 | 360,000.00 |
| Sep 30, 2013 | 3.61 Mn |
| Jun 30, 2013 | 4.71 Mn |
| Dec 31, 2012 | 1.85 Mn |